07:44 AM EDT, 10/31/2024 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) reported Q3 non-GAAP earnings Thursday of $1.80 per diluted share, down from $2 a year earlier.

Analysts polled by Capital IQ expected $1.50.

Total revenue for the quarter ended Sept. 30 was $11.89 billion, up from $10.97 billion a year earlier.

Analysts surveyed by Capital IQ expected $11.25 billion.

For 2024, the biopharmaceutical company said it now expects non-GAAP diluted EPS of $0.75 to $0.95, up from its prior guidance for $0.60 to $0.90. Analysts polled by Capital IQ expect $0.71.

Bristol-Myers shares were up 2.8% in recent premarket activity.